Related Experiment Video

Updated: Jun 4, 2025

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.7K

Response to reader comment on: "Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir"

Patricia A Escobar1, Zhanna Sobol1, Randy R Miller1

  • 1Nonclinical Drug Safety and Pharmacokinetics Dynamics Metabolism and Bioanalysis, Preclinical Development, Merck & Co. Inc., Rahway, NJ 07065, United States.

Toxicological Sciences : an Official Journal of the Society of Toxicology
|December 18, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response
05:01

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response

Published on: June 14, 2024

1.1K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.8K

Related Experiment Videos

Last Updated: Jun 4, 2025

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.7K
Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response
05:01

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response

Published on: June 14, 2024

1.1K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.8K

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Mismatch Repair01:20

Mismatch Repair

4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K

Articles linked to this work by shared authors, journal, and citation graph.

Investigation of a metabolism-dependent aryl hydrocarbon receptor off-target activation for a drug development candidate and a screening strategy for de-risking backups.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Reduction in estimated glomerular filtration rate observed with doravirine is caused by inhibition of organic cation transporter 2.

Drug metabolism and disposition: the biological fate of chemicals·2026

Urinary tract infection in the neonatal intensive care unit.

Journal of perinatology : official journal of the California Perinatal Association·2026

Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease.

Journal of medicinal chemistry·2026

Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data.

Regulatory toxicology and pharmacology : RTP·2026

Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis.

Nature medicine·2026

The aryl hydrocarbon receptor as a tissue-specific modulator of insulin sensitivity: Evidence from conditional deletion studies.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Acute Exposure to Perfluorooctanoic Acid (PFOA) During Cardiomyogenesis disrupts Transcriptional and Electrophysiological Profiles in Differentiated Myocytes.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Nonclinical Investigation of the Potential of MHAA4549A, an Anti-Influenza A Therapeutic Antibody, to Mediate Antibody-Dependent Enhancement.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Advancing genotoxicity assessment with transcriptomic biomarkers: From 2D to 3D HepaRG spheroid models.

Toxicological sciences : an official journal of the Society of Toxicology·2026

In Vitro Approaches to Assess Respiratory Toxicity from Volatile Organic Compounds: An In-Depth Review.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Effects of phthalates on mammalian adipose tissue.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Salvage prostate therapies for local pelvic recurrence after primary radiation for prostate cancer.

BJUI compass·2026

Gantry-period-guided modulation factor selection in helical tomotherapy: effects on delivery efficiency, dosimetry and verification accuracy.

Frontiers in oncology·2026

A Monte Carlo based dose verification tool for an HDR Ir-192 brachytherapy source and its evaluation on extremity malignancies.

Journal of applied clinical medical physics·2026

Pulmonary ventilation images from planning CT images using deep learning on locally-advanced NSCLC patients.

Journal of applied clinical medical physics·2026

Herpetic reactivation during radiotherapy treatment for gynaecological cancers-a retrospective observational study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Radiodynamic Therapy Using Local Administration of 5-Aminolevulinic Acid for In Vivo Osteosarcoma Xenograft Model.

In vivo (Athens, Greece)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us